Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.

被引：0
|
作者：
Moon, Helen H. [1 ]
Kearney, Mairead [2 ]
Mahmoudpour, Seyed Hamidreza [2 ]
Ike, Chiemeka [3 ]
Morris, Valerie A. [3 ]
Rava, Andrew [4 ]
Kim, Sonia [5 ]
Sun, Haiyan [5 ]
Boyd, Marley [5 ]
Rey, Gabriel Gomez [5 ]
机构：
[1] Kaiser Permanente, Riverside, CA USA
[2] Healthcare Business Merck KGaA, Darmstadt, Germany
[3] EMD Serono, Rockland, MA USA
[4] Genesis Res, Hoboken, NJ USA
[5] Genesis Res LLC, Hoboken, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-183-138-12268; 130-544; 261-492-9019; 298-145-222-9001; 261-492-3532-2370-7650-2700; 261-566-9263; 6; 4; 3; 2; 1880; 1876; 3224; 295; 12; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [41] Maintenance therapy with avelumab as the first-line treatment in patients with metastatic urothelial carcinoma: A real-world, ambispective RAVE-Bladder study.
    Gridneva, Yana
    Sultanbaev, Alexander, Sr.
    Anzhiganova, Yulia
    Gluzman, Mark
    Mochalova, Anastasia
    Shkurat, Alexey
    Parsadanova, Elvira
    Israelyan, Edgar
    Murzina, Yulia
    Kalpinsky, Aleksey
    Stativko, Olesia
    Karabina, Elena
    Kfln, Artyom
    Petkau, Vladislav
    Tovbik, Natalya
    Turganova, Maria
    Safina, Sufiia
    Kopyltsov, Evgeny
    Volkova, Maria
    Tsimafeyeu, Ilya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] FIRST-LINE TREATMENT PATTERNS AMONG PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER (LA/MUC): A SYSTEMATIC LITERATURE REVIEW
    Kearney, M.
    Zhang, L.
    Hubscher, E.
    Musat, M.
    Harricharan, S.
    Wilke, T.
    VALUE IN HEALTH, 2022, 25 (12) : S414 - S414
  • [43] Real-world outcomes of metastatic urothelial carcinoma (mUC) patients (pts) treated with first or second-line immunotherapies (10) in the United States (US)
    Boyd, Marley
    Annavarapu, Srinivas
    Doshi, Gurjyot K.
    Imai, Kentaro
    Sbar, Eric
    Godwin, James Luke
    Li, Haojie
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] COST-EFFECTIVENESS ANALYSIS OF AVELUMAB PLUS BEST SUPPORTIVE CARE (BSC) AS FIRST-LINE MAINTENANCE TREATMENT IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) IN FRANCE
    Plessala, I
    Cawston, H.
    Roiz, J.
    Xiao, Y.
    Kearney, M.
    Chang, J.
    Porte, F.
    Granghaud, A.
    Morel, A.
    Ravaud, A.
    Loriot, Y.
    Thiery-Vuillemin, A.
    Levy, P.
    VALUE IN HEALTH, 2022, 25 (12) : S113 - S113
  • [45] Real-world (RW) treatment (Tx) patterns and clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC): Results of a nationwide, longitudinal, retrospective study in Hungary
    Maraz, A. C.
    Nagy, B.
    Macher, T.
    Jesko, J.
    Tischler, E.
    Csongvai, C.
    Kearney, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1341 - S1341
  • [46] Subgroup analyses of patients (pts) with advanced urothelial carcinoma (aUC) who had long-term progression-free survival (PFS) or overall survival (OS) with avelumab first-line maintenance (1LM) in the AVENANCE real-world study
    Barthelemy, P.
    Eymard, J-C.
    Flechon, A.
    Goupil, M. Gross
    Voog, E.
    Loriot, Y.
    Jaillon, C. Abraham
    Gobert, A.
    Chasseray, M.
    Kazan, E.
    Josse, C.
    Lambert, P.
    Paret, L.
    Thibault, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S1151 - S1152
  • [47] Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel
    Cowey, Charles Lance
    Liu, Frank X.
    Kim, Ruth
    Boyd, Marley
    Fulcher, Nicole
    Krulewicz, Stan
    Kasturi, Vijay
    Bhanegaonkar, Abhijeet
    FUTURE ONCOLOGY, 2021, 17 (18) : 2339 - 2350
  • [48] Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France
    Porte, Fanny
    Granghaud, Anna
    Chang, Jane
    Kearney, Mairead
    Morel, Aya
    Plessala, Ingrid
    Cawston, Helene
    Roiz, Julie
    Xiao, Ying
    Solbes, Marie-Noelle
    Lambert, Prisca
    Ravaud, Alain
    Loriot, Yohann
    Thiery-Vuillemin, Antoine
    Levy, Pierre
    PLOS ONE, 2024, 19 (05):
  • [49] Real-world treatment patterns, survival outcomes, and health care resource utilization (HCRU) for locally advanced or metastatic urothelial carcinoma (la/mUC) in Spain.
    Puente, Javier
    Pinto, Alvaro
    Vidal, Maria Jose Mendez
    del Muro, Xavier Garcia
    Maroto-Rey, Pablo
    Vazquez-Estevez, Sergio
    Luque, Raquel
    Anido, Urbano
    Strunz-McKendry, Torsten
    Upadhyay, Anil
    Montes, Jose
    Nunez, Aurora Ortiz
    Portela, Judit Gonzalez
    Castellano, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [50] Real-world (RW) systemic treatment patterns and clinical outcomes in locally advanced (LA) and recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC) patients (pts).
    Thao Vo
    Boyd, Marley
    Espirito, Janet L.
    Gumuscu, Burak
    Chirovsky, Diana Romana
    Robert, Nicholas J.
    Swaby, Ramona F.
    Zhou, Wei
    Cowey, Charles Lance
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345